Tag: miracl

Classics Series, Landmark Trials in Medicine

The MIRACL trial: Atorvastatin reduces recurrent ischemia post-ACS [Classics Series]

byAndrew Cheung, MD MBA

November 9, 2014

1. In patients with recent acute coronary syndrome, atorvastatin 80 mg daily reduced the risk of recurrent ischemia in the ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

Artificial intelligence (AI)-based coronary calcium quantification successfully identified patients who could benefit from lipid-lowering therapy
First messenger RNA influenza vaccine outperforms standard-dose vaccination
Few interventions improve posthospitalization follow-up for alcohol use disorder

No Result

View All Result

Tag: miracl

The MIRACL trial: Atorvastatin reduces recurrent ischemia post-ACS [Classics Series]

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits